New Delhi [India], October 9: MSN Laboratories, a leading global Indian pharmaceutical company, today announced that it is the first to launch the revolutionary JAK inhibitor molecules Tofacitinib (Tofadoz) and Upadacitinib (Upadoz) in India.
Ahmedabad (Gujarat) [India], June 29: Intas Pharmaceuticals Ltd., one of India's leading pharmaceutical companies with operations across the globe has launched TOFATAS - a DCGI-approved, Tofacitinib Ointment 2 per cent w/w for the treatment of mild to moderate Atopic Dermatitis (AD) in patie
California [US], September 30 (ANI): A team of researchers found that the drug tofacitinib, also called Xeljanz and approved by the FDA to treat rheumatoid arthritis and ulcerative colitis, can repair permeability defects in the intestine.